Enteric bacterial infections, notably shigellosis and salmonellosis, represent a staggering global health burden. Vaccine development is severely hampered by host-restriction, creating a persistent "translational gap" where preclinical data fails to correlate with human outcomes. Traditionally, model selection has been...
Hemanta Koley, Arindam Mukherjee, A. Mukhopadhyay et al.· Vaccine· 0 citations
These findings establish this commensal E. coli (HK5) as a potent probiotic candidate with dual preventative and therapeutic efficacy, offering a promising non-antibiotic strategy to combat diarrheal diseases.
It is established that the vaccine formulation can effectively boost and redirect pre-existing immunity, offering a promising approach to overcome the limitations of natural exposure and protect at-risk individuals from diverse Pa infections.
D. R. Howlader, Sayan Das, Satabdi Biswas et al.· Infection and Immunity· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.